№ lp_1_04036
File format: docx
Character count: 4110
File size: 198 KB
This document outlines the procedure for conducting an initial fact-finding exercise in response to concerns about an employee’s conduct or performance within an organization.
Note:
Year
Topic:
Incident Investigation
Document Type:
Report
Target Audience:
Management, HR, Investigation Team
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / City:
Venezuela
Topic:
Human Rights Violations
Document Type:
Conference Room Paper
Organization / Institution:
United Nations Human Rights Council
Author:
Independent International Fact-Finding Mission
Target Audience:
Governments, International Organizations, Human Rights Advocates
Period of Action:
1 September 2023 – 31 August 2024
Approval Date:
14 October 2024
Date of Amendments:
None
Note:
Contextual description
Year:
2020
Region / city:
Montreal, Canada
Topic:
Digital Sequence Information, Genetic Resources, Benefit-Sharing, Access and Benefit Sharing (ABS), Research and Development
Document type:
Report
Organization / institution:
Executive Secretary, Conference of the Parties to the Convention on Biological Diversity
Author:
Executive Secretary
Target audience:
Parties to the Convention on Biological Diversity, stakeholders in genetic resource management, researchers
Period of validity:
2020
Date of approval:
January 2020
Date of amendments:
None
Context:
The document reports on a study commissioned to evaluate how countries address benefit-sharing and the use of digital sequence information on genetic resources in both commercial and non-commercial contexts.
Year:
2018
Region / city:
Myanmar
Subject:
Human Rights Violations and Abuses in Myanmar
Document Type:
Report
Institution:
Human Rights Council
Author:
Independent International Fact-Finding Mission on Myanmar
Target Audience:
International community, policy makers, human rights organizations
Period of validity:
2011–2018
Approval Date:
12 September 2018
Date of changes:
N/A
Year:
2026
Region / City:
Not specified
Topic:
Neuropsychological assessment
Document Type:
Assessment report
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Clinicians, neuropsychologists, medical professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Revision Date:
Not specified
Year:
20XX
Region / city:
Texas
Subject:
Thesis/Dissertation
Document Type:
Thesis/Dissertation Template
Author:
[Insert full name here]
Target Audience:
Graduate Students, Academic Institutions
Period of Action:
[Month and year of graduation]
Date of Approval:
[Month and year]
Date of Changes:
[If applicable]
Investigator:
[insert name of principal investigator]
Key Information:
The following is a short summary of this study to help you decide whether or not to be a part of this study. More detailed information is listed later on in this form.
Note:
Why am I being invited to take part in a research study?
You will be asked to _________ [include a high level summary of the procedures that will be done. For example:
You will be given an investigational drug and asked to come for 3 study visits. You will give a total of 3 blood samples and fill out questionnaires asking about how you feel.]
Instead of being in this research study, your choices may include:
[List alternatives procedures. For student subject pools describe alternatives for course credit. For clinical trials describe the options that you would normally offer patient. If applicable, include supportive care as an option.]
Detailed Information:
The following is more detailed information about this study in addition to the information listed above.
[Tell the subject what to expect using lay language and simple terms. Whenever appropriate include the following items:
]
Note:
Year
Topic:
Medical Treatment Request
Document Type:
Letter
Author:
[Insert Healthcare Provider’s Name]
Target Audience:
Insurance Company
Year:
2025
Region / City:
[insert local health board name]
Topic:
Community Pharmacy, Common Ailments Service, Docusate Sodium
Document Type:
Patient Group Direction (PGD)
Organization / Institution:
Welsh Medicines Advice Service
Author:
Dianne Burnett
Target Audience:
Pharmacists working within the Common Ailments Service of the Clinical Community Pharmacy Service
Period of Validity:
01 November 2025 - 31 October 2028
Approval Date:
29 August 2025
Review Date:
31 July 2028
Expiration Date:
31 October 2028
Year:
2025
Region / city:
[insert local health board name]
Theme:
Vaccination
Document type:
Patient Group Direction (PGD)
Authorising organisation:
NHS Wales
Target audience:
Healthcare professionals (Registered)
Period of validity:
01 September 2025 - 31 March 2026
Approval date:
07 August 2025
Amendment date:
30 June 2025
Review date:
01 July 2026
Expiry date:
31 March 2026
Note:
Year
Type of Document:
Charter / Standard Operating Procedure
Study Phase:
Clinical Trial
Responsibilities:
Participant safety monitoring, data quality assessment, trial progress evaluation
Membership:
DSMB Chair, Voting Members, Independent Medical Monitor (if applicable)
Conflict of Interest Policy:
Disclosure and management of real or apparent conflicts
Meeting Requirements:
Quorum and attendance rules
Stopping Criteria:
Safety concerns and trial halting conditions
Year:
2026
Region / City:
Cairns, Queensland
Document Type:
Development Application Report
Author:
Accredited Consultant
Accreditation Number:
[INSERT]
Application Number:
[INSERT]
Planning Scheme:
CairnsPlan 2016
Development Type:
[Insert Development type]
Site Address:
[INSERT ADDRESS]
Lot and Plan:
[INSERT]
Landowner:
[INSERT]
Applicant:
[INSERT]
Date of Application:
[INSERT]
Appendices:
Plans of development, Consultant report
Year:
[insert]
Region / City:
[insert]
Type of document:
Contract Agreement
Institution:
[insert name of school] Board of Trustees
Contractor:
[insert full legal name of Contractor]
Commencement Date:
[insert]
Insurance:
Public liability insurance $2,000,000; Contractor’s plant and equipment insured if over $25,000
Health and Safety:
Site-specific risk assessment and safety plan required
Design Responsibility:
[None or insert description]
Subcontractors and Suppliers:
[insert]
Salvaged Materials:
[None or insert list]
Context:
Contract document establishing obligations, responsibilities, and insurance arrangements for construction work at a school, detailing terms, schedules, and risk management requirements.
Note:
Year
Topic:
Land Use Planning
Document type:
Committee Resolution
Organization / institution:
Navajo Nation
Author:
Navajo Nation Department of Justice
Target audience:
Community members of the Chapter
Effective period:
Ongoing
Year:
2024
Region / City:
Wales
Topic:
Healthcare, Pharmacy, Urinary Tract Infection
Document Type:
Patient Group Directions (PGD)
Organisation:
Welsh Medicines Advice Service, NHS Wales
Author:
Dianne Burnett, Louise Allen, Emlyn Pritchard, Adam Mackridge, Richard Coulthard
Target Audience:
Healthcare professionals, community pharmacists
Validity Period:
From 03 June 2024 to 02 June 2027
Approval Date:
22 April 2024
Ratification Date:
09 May 2024
Review Date:
08 February 2027
Expiry Date:
02 June 2027
Version:
1.0
Change History:
Version 1.0 developed on 22 December 2023
Clinical Condition:
Acute, uncomplicated lower urinary tract infection
Treatment:
Nitrofurantoin, Trimethoprim
Applicable Group:
Non-pregnant females or transgender males (16-64 years)
Authorising Organisation:
Local Health Board
Staff Requirements:
Registered pharmacists, authorised by name
Retention Period:
8 years for adults, 25 years for children
Local Inquiries:
[insert local details]
Note:
Year
Region / City:
Ohio
Subject:
Architecture/Engineering Agreement
Document Type:
Contract
Organ / Institution:
State of Ohio
Year:
[DATE]
Region / City:
[LOCATION]
Topic:
Preliminary Design Review, Engineering, Defense Systems
Document Type:
Executive Summary, Report
Organization / Institution:
[OFFICE CONDUCTING THE ASSESSMENT]
Author:
[NAME OF AUTHOR, IF AVAILABLE]
Target Audience:
Milestone Decision Authority, Program Management, Stakeholders
Period of Effectiveness:
[DATE]
Approval Date:
[DATE OF APPROVAL, IF AVAILABLE]
Date of Amendments:
[DATE, IF AVAILABLE]
Year:
2023
Region / City:
Canberra
Topic:
Diabetes management, exercise therapy
Document Type:
Procedure
Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Clinicians, healthcare professionals
Period of Validity:
Indefinite
Approval Date:
Not specified
Date of Changes:
Not specified